Novartis Quarterly Results for Trading Insights

NOVARTIND • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹101 Cr
QMarch 2025
Quarterly Results

Novartis Quarterly Results Key Highlights

  • Revenue of ₹398 Cr in March 2025 (+0.0% vs March 2025, +0.3% vs March 2024)
  • Net Profit of ₹101 Cr in March 2025 (+0.0% vs March 2025, +18.8% vs March 2024)
  • EBITDA of ₹133 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 26.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹40.87 in March 2025 (+0.0% vs March 2025)

Novartis Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 396 398 397 437 433 -0.5% -
Net Profit (₹ Cr) 107 101 85 103 -4 - -
EBITDA (₹ Cr) 142 133 127 123 60 - -
EPS (₹) 43.20 40.87 34.50 41.86 -1.51 - -
Operating Margin (%) 28.0% 26.0% 19.0% 17.0% 7.0% - -

Novartis Share Price Trend Around Quarterly Results

Visualize Novartis's 1-year price movement across quarterly results — ideal for logging trades in Novartis share price chart using Tickjournal. All values in ₹.

Related Pages for Novartis

Additional stock information and data for NOVARTIND

NOVARTIND fair value
NOVARTIND P/E comparison
NOVARTIND stock price history
NOVARTIND price range
NOVARTIND complete financial
NOVARTIND Benjamin Graham valuation
Novartis share price chart

Profitability Ratios

Profit Margin 25.4%
EBITDA Margin 33.4%
Operating Margin 26.0%
ROE (Annual) 12.9%

Balance Sheet Highlights

Total Assets ₹948 Cr
Total Equity ₹785 Cr
Current Assets ₹746 Cr
Current Liabilities ₹21 Cr

Cash Flow Analysis

Operating Cash Flow ₹75 Cr
Investing Cash Flow ₹-3 Cr
Financing Cash Flow ₹-64 Cr
Net Cash Flow ₹7 Cr

Current Market Data

Current Price ₹800.75
Exchange BSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

March 2023 437
March 2024 397
March 2025 398
2026 396

Net Profit Trend (₹ Cr)

March 2023 103
March 2024 85
March 2025 101
2026 107

Operating Margin Trend (%)

March 2023 17.0%
March 2024 19.0%
March 2025 26.0%
2026 28.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Novartis quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores